Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Blass

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Bioorganic & Medicinal Chemistry|August 16, 2012
Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profilingMark E McDonnell, Matthew D Vera, Benjamin E Blass, et al.
Journal of Medicinal Chemistry|November 6, 2009
Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmiaBenjamin E Blass, Andrew Fensome, Eugene Trybulski, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2006
Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillationBenjamin E Blass, Keith Coburn, Wenlin Lee, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Rescuing the Function of Missense-Mutated Tumor Suppressor <i>VHL</i> using Stabilizing Small MoleculesMariam Ahmed Fouad, Christopher S Parry, Sven A Miller, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2016
Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic SyndromeBenjamin E Blass, Pravin Iyer, Magid Abou-Gharbia, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2018
Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17)Benjamin E Blass, Pravin Iyer, Magid Abou-Gharbia, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Bioorganic & Medicinal Chemistry|August 16, 2012
Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profilingMark E McDonnell, Matthew D Vera, Benjamin E Blass, et al.
Journal of Medicinal Chemistry|November 6, 2009
Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmiaBenjamin E Blass, Andrew Fensome, Eugene Trybulski, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2006
Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillationBenjamin E Blass, Keith Coburn, Wenlin Lee, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Rescuing the Function of Missense-Mutated Tumor Suppressor <i>VHL</i> using Stabilizing Small MoleculesMariam Ahmed Fouad, Christopher S Parry, Sven A Miller, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2016
Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic SyndromeBenjamin E Blass, Pravin Iyer, Magid Abou-Gharbia, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2018
Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17)Benjamin E Blass, Pravin Iyer, Magid Abou-Gharbia, et al.
Pageof 6